A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer
Advanced Science · 2025
DOI: 10.1002/advs.202413913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xueying Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Translational Research, Peking Universit…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Immunotherapy, Claudins, Hyperthermia, Induced. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Fund for Key Projects of National Natural Science Foundation of China, National Natural Science Foundation of China, Natural Science Foundation of Beijing.
Abstract (Originalsprache)
Precision treatment of gastric cancer requires specific biomarkers, and CLDN18.2 emerges as a promising target for patients’ stratification and therapeutic guidance. In 563 cases, 54.4% of patients are identified as CLDN18.2‐positive, with CLDN18.2 expression negatively correlated with immune‐related factors like PD‐L1, indicating a “cold” tumor microenvironment. Here, a novel CLDN18.2 monoclonal antibody 1D5 is created with superior high specificity and affinity, and the antibody‐dependent fluorescence‐magnetic nanoparticle is developed for specific detection and magnetic hyperthermia (MHT). Under the assistance of sensitive fluorescence and deep‐penetrating magnetic particle imaging for tracing and timing the optimal nanoparticle dosage, MHT induces robust immunogenic response via DNA mismatch repair and tumor‐associated antigen release. It recruits CD11c + dendritic cells, compensates PD‐1 in CD8 + T cells, and enhances CD86 + macrophage polarization. The combination of anti‐PD‐1 therapy increased TNF‐α and IFN‐γ secretion and further boosted the cytotoxic efficacy of CD8 + T cells. Excellent therapeutic efficacy is found simultaneously on cell‐derived allografts and patient‐derived xenografts based on this spatiotemporally manipulated strategy, presenting a therapeutic option for enhancing responsiveness to immunotherapy for CLDN18.2‐positive individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Translational Research, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
- CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
- University of Chinese Academy of Sciences, Beijing, 100080, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
- School of Engineering Medicine & School of Biological Science and Medical Engineering, Beihang University, Beijing, 100191, China.
- Key Laboratory of Big Data-Based Precision Medicine (Beihang University), Ministry of Industry and Information Technology of China, Beijing, 100191, China.
ORCID-Profile: Jiafu Ji
Förderung
- Joint Fund for Key Projects of National Natural Science Foundation of China
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing
- Science Foundation of Peking University Cancer Hospital
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wang, X., Hui, H., Han, J., Guo, T., Wang, Y., Meng, L., Chen, C., He, J., Guo, X., Zhong, F., Du, H., Tian, J., Xing, X., Du, Y., & Ji, J. (2025). A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer. Advanced Science. https://doi.org/10.1002/advs.202413913
Vancouver
Wang X, Hui H, Han J, Guo T, Wang Y, Meng L, et al. A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer. Advanced Science. 2025. doi:10.1002/advs.202413913
BibTeX
@article{Wang2025,
author = {Wang, Xueying and Hui, Hui and Han, Jing and Guo, Ting and Wang, Yiding and Meng, Lin and Chen, Cong and He, Jie and Guo, Xiaoyong and Zhong, Fuyu and Du, Hong and Tian, Jie and Xing, Xiaofang and Du, Yang and Ji, Jiafu},
title = {A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202413913}
}
EUVIMED